2 Years of Immunotherapy for Advanced Lung Cancer Might Be Enough: Study

FRIDAY, June 9, 2023 -- For patients battling late-stage lung cancer, prospects for survival have improved significantly since the advent of medications known as immune checkpoint inhibitors. But exactly how long patients with advanced non-small...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news